[go: up one dir, main page]

AU2001290962A1 - Methods of preparing immune globulin and uses thereof - Google Patents

Methods of preparing immune globulin and uses thereof

Info

Publication number
AU2001290962A1
AU2001290962A1 AU2001290962A AU9096201A AU2001290962A1 AU 2001290962 A1 AU2001290962 A1 AU 2001290962A1 AU 2001290962 A AU2001290962 A AU 2001290962A AU 9096201 A AU9096201 A AU 9096201A AU 2001290962 A1 AU2001290962 A1 AU 2001290962A1
Authority
AU
Australia
Prior art keywords
methods
immune globulin
preparing immune
conditions
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290962A
Inventor
William Pollack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atopix Pharmaceuticals Corp
Original Assignee
Atopix Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atopix Pharmaceuticals Corp filed Critical Atopix Pharmaceuticals Corp
Publication of AU2001290962A1 publication Critical patent/AU2001290962A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention provides for methods of preparing purified immune globulins, immune globulin compositions, and methods of treating allergies and conditions by administering immune globulin compositions. For example, the present invention provides for purified IgG4 that is essentially free of other IgG subtypes that can be used to treat allergies and other conditions.
AU2001290962A 2000-09-13 2001-09-13 Methods of preparing immune globulin and uses thereof Abandoned AU2001290962A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/660,862 US6962700B1 (en) 2000-09-13 2000-09-13 Method of manufacturing immune globulin
US09/660,862 2000-09-13
PCT/US2001/028830 WO2002022079A2 (en) 2000-09-13 2001-09-13 Methods of preparing immune globulin and uses thereof

Publications (1)

Publication Number Publication Date
AU2001290962A1 true AU2001290962A1 (en) 2002-03-26

Family

ID=24651263

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290962A Abandoned AU2001290962A1 (en) 2000-09-13 2001-09-13 Methods of preparing immune globulin and uses thereof

Country Status (6)

Country Link
US (2) US6962700B1 (en)
EP (1) EP1320351B1 (en)
AT (1) ATE401912T1 (en)
AU (1) AU2001290962A1 (en)
DE (1) DE60134993D1 (en)
WO (1) WO2002022079A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257972A1 (en) * 2003-03-31 2006-11-16 Takashi Ishihara Purification of human monoclonal antibody and human polyclonal antibody
ATE468390T1 (en) * 2004-10-13 2010-06-15 Protalix Ltd SYSTEM AND METHOD FOR PRODUCING ANTIBODIES IN PLANT CELL CULTURE
TWI391399B (en) * 2005-05-25 2013-04-01 Hoffmann La Roche Method for determining the concentration of a salt for eluting a polypeptide
AU2008256411B2 (en) 2007-06-01 2013-08-22 F. Hoffmann-La Roche Ag Immunoglobulin purification
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10232048B1 (en) 2014-11-18 2019-03-19 Divine Api-Logics, LLC Apitherapy method and composition
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US20220324961A1 (en) * 2021-04-12 2022-10-13 IgGenix, Inc. Allergy therapy
US20230174632A1 (en) * 2021-12-08 2023-06-08 IgGenix, Inc. Combinations for allergy therapy

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089944A (en) * 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
DE2837168A1 (en) 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz METHOD FOR PRODUCING AN IMMUNAL GLOBULIN SOLUTION SUITABLE FOR INTRAVENOUS APPLICATION
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
JPS57206608A (en) 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4482483A (en) 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4719290A (en) 1983-09-02 1988-01-12 Armour Pharmaceutical Corporation Composition of intravenous immune globulin
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
JPS61286754A (en) 1985-06-12 1986-12-17 Shionogi & Co Ltd Monoclonal anti-human igg4 antibody and its preparation
US5346687A (en) * 1989-08-09 1994-09-13 Rhomed Incorporated Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
US5177194A (en) 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
CA2078805C (en) 1992-09-22 1997-02-25 Intelcor Biotech Enterprises Inc. Cytokine preparation
US5489519A (en) * 1992-10-27 1996-02-06 Queen's University At Kingston Multidrug resistance protein
IT1257184B (en) * 1992-12-22 1996-01-10 Applied Research Systems PREPARED FOR ANTI-INFLAMMATORY, ANTI-AGULANT AND ANTI-TUMORAL ACTIVITY
FR2706466B1 (en) 1993-06-14 1995-08-25 Aetsrn Immunoglobulin G concentrate for therapeutic use and process for producing said concentrate.
US6165981A (en) * 1995-03-07 2000-12-26 Dade Behring Inc. Stabilizing solutions for proteins and peptides
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product

Also Published As

Publication number Publication date
US6962700B1 (en) 2005-11-08
US20020064526A1 (en) 2002-05-30
EP1320351B1 (en) 2008-07-23
WO2002022079A2 (en) 2002-03-21
US7276236B2 (en) 2007-10-02
ATE401912T1 (en) 2008-08-15
DE60134993D1 (en) 2008-09-04
WO2002022079A3 (en) 2002-11-07
EP1320351A2 (en) 2003-06-25
EP1320351A4 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
AU2002360592A8 (en) Inhibitors of hepatitis c virus
WO2005016962A3 (en) Compositions and methods for the treatment of immune related diseases
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
ATE519501T1 (en) RECOMBINANT ANTI-CD40 ANTIBODIES AND APPLICATIONS THEREOF
WO2003000200A3 (en) β-2'-OR 3'-HALONUCLEOSIDES
MXPA03011515A (en) Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents.
DK0703922T3 (en) Process for Preparation of Immunoglobulin G Concentrate
EP1425031B8 (en) Hdl for the treatment of stroke and other ischemic conditions
AU2001290962A1 (en) Methods of preparing immune globulin and uses thereof
ZA202209119B (en) Anti-human cd19 antibodies
PL374080A1 (en) Processes for the preparation of fibrinogen
ATE348812T1 (en) QUINOLINE AND QUINAZOLINE DERIVATIVES AS ANTAGONISTS OF THE CORTICOTROPIN RELEASING FACTOR (CRF)
WO2022173714A3 (en) Antibodies that bind metapneumovirus, antigenic metapneumovirus proteins, and uses thereof
ATE199321T1 (en) ANTI-IDIOTYPIC ANTIBODIES AGAINST GONOCOCCES AND METHODS AND COMPOSITIONS USING SAME.
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
EP1401496A4 (en) Compositions and methods for treating hyperimmune response in the eye
WO2002060954A8 (en) Materials and methods for treatment of hepatitis c
ATE201601T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A NEUTRALIZED VIRUS AND USE THEREOF
DE69636527D1 (en) ANTIGENE PROTEIN FROM MALASSEZIA
WO2001072334A3 (en) Methods for treating disease with antibodies to cxcr3
WO2003028666A3 (en) Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
IL154775A (en) 21-hydroxy- 6,19-oxidoprogesterone (21oh-6, 19op) analogues, their preparation and use
ATE412423T1 (en) PEROXIREDOXIN DRUGS FOR TREATING HIV-1 INFECTION